Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
35.03
-0.26 (-0.74%)
At close: Jan 22, 2026, 4:00 PM EST
35.03
0.00 (0.00%)
After-hours: Jan 22, 2026, 6:10 PM EST

Immunocore Holdings Revenue

Immunocore Holdings had revenue of $103.69M in the quarter ending September 30, 2025, with 29.22% growth. This brings the company's revenue in the last twelve months to $379.59M, up 28.10% year-over-year. In the year 2024, Immunocore Holdings had annual revenue of $310.20M with 24.37% growth.

Revenue (ttm)
$379.59M
Revenue Growth
+28.10%
P/S Ratio
4.67
Revenue / Employee
$769,959
Employees
493
Market Cap
1.77B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024310.20M60.77M24.37%
Dec 31, 2023249.43M75.07M43.05%
Dec 31, 2022174.36M137.88M377.91%
Dec 31, 202136.48M-4.63M-11.26%
Dec 31, 202041.11M7.12M20.94%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MannKind313.79M
Stoke Therapeutics205.63M
Zymeworks134.48M
Syndax Pharmaceuticals111.30M
Upstream Bio2.80M
Celldex Therapeutics2.60M
Revenue Rankings